Asian markets ended mostly higher on Tuesday as expectations of a Covid-19 vaccine bolstered investors' sentiment. After Pfizer, US pharma giant Moderna has published its own preliminary analysis indicating its own vaccine had 94.5 percent effectiveness in preventing corona virus. Japanese shares ended marginally higher as reports of another promising corona virus vaccine re-ignited hope of a quick global recovery. However,, Chinese shares weighed down by losses in healthcare stocks on worries over lofty valuations, while more bond defaults hit sentiment.
| |||||||||||||||||||||||||||||||||||||
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: